1N9J | B:4-92; B:4-92 | SOLUTION STRUCTURE OF THE 3D DOMAIN SWAPPED DIMER OF STEFIN A |
1NB3 | L:9-119; L:9-119; L:9-119; L:9-119 | CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H: N-TERMINAL RESIDUES OF INHIBITORS CAN ADAPT TO THE ACTIVE SITES OF ENDO-AND EXOPEPTIDASES |
1NB5 | L:9-119; L:9-119; L:9-119; L:9-119 | CRYSTAL STRUCTURE OF STEFIN A IN COMPLEX WITH CATHEPSIN H |
3K9M | D:4-92; D:4-92 | CATHEPSIN B IN COMPLEX WITH STEFIN A |
3KFQ | D:4-92; D:4-92 | UNREDUCED CATHEPSIN V IN COMPLEX WITH STEFIN A |
1STF | I:9-119 | THE REFINED 2.4 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF RECOMBINANT HUMAN STEFIN B IN COMPLEX WITH THE CYSTEINE PROTEINASE PAPAIN: A NOVEL TYPE OF PROTEINASE INHIBITOR INTERACTION |
2OCT | B:4-92; B:4-92 | STEFIN B (CYSTATIN B) TETRAMER |
1R4C | H:11-106; H:11-106; H:11-106; H:11-106; H:11-106; H:11-106; H:11-106; H:11-106 | N-TRUNCATED HUMAN CYSTATIN C; DIMERIC FORM WITH 3D DOMAIN SWAPPING |
1TIJ | B:11-106; B:11-106 | 3D DOMAIN-SWAPPED HUMAN CYSTATIN C WITH AMYLOID-LIKE INTERMOLECULAR BETA-SHEETS |
3NX0 | B:12-106; B:12-106 | HINGE-LOOP MUTATION CAN BE USED TO CONTROL 3D DOMAIN SWAPPING AND AMYLOIDOGENESIS OF HUMAN CYSTATIN C |
1RN7 | A:12-108 | STRUCTURE OF HUMAN CYSTATIN D |
1ROA | A:12-108 | STRUCTURE OF HUMAN CYSTATIN D |